Patient Guide: A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 59 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06868212
Status: 🟢 Enrolling Now
Condition: Chronic Spontaneous Urticaria (CSU)
Phase: PHASE3

Where You Can Participate

This study is available at 59 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Litchfield Park, Arizona
  • • Phoenix, Arizona
  • • And 56 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines - Join Clinical Trial NCTNCT06868212

How to Join This Clinical Trial - NCTNCT06868212

Learn how to participate in this PHASE3 trial studying an investigational therapy for Chronic Spontaneous Urticaria (CSU). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Spontaneous Urticaria (CSU). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Spontaneous Urticaria (CSU)
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06868212 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 59 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: RECRUITING

Clinical Research Site

Litchfield Park, Arizona 85340 - United States

Status: RECRUITING

Clinical Research Site

Phoenix, Arizona 85032 - United States

Status: RECRUITING

Clinical Research Site

Little Rock, Arkansas 72205 - United States

Status: RECRUITING

Clinical Research Site

Fremont, California 95438 - United States

Status: RECRUITING

Clinical Research Site

Huntington Beach, California 92647 - United States

Status: RECRUITING

Clinical Research Site

Long Beach, California 90808 - United States

Status: RECRUITING

Clinical Research Site

Long Beach, California 90815 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90025 - United States

Status: RECRUITING

Clinical Research Site

Los Angeles, California 90045 - United States

Status: RECRUITING

And 49 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Chronic Spontaneous Urticaria (CSU):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships